Here are relevant reports on : mental-health-digital-therapeutics-market
-
Prostate Cancer Therapeutics Market (2010-2020) (Opportunity Analysis, Pipeline Assessment and Global Market Forecast)
Prostate cancer is the most frequently diagnosed cancer in men. In terms of loss of life from any disease, prostate cancer ranks eleventh; and it ranks sixth in terms of cancer-related mortality in men. The prostate cancer market has a huge demand for new and novel drugs that address unmet needs such as improved survival time, less toxicity, increased progression free survival, increased effectiveness, and lower cost.
- Published: November 2011
- Price: $ 4950
- TOC Available:
-
Lung Cancer Therapeutics Market (NSCLC & SCLC) - 2010-2020 (Pipeline Assessment and Market Forecast) in G7 countries
Lung cancer is responsible for most of the deaths (due to cancer) across the globe. With just one drug slated to be launched by 2014 – Talactoferrin by Agennix AG, for patients with advanced lung cancer; having failed both chemotherapy and treatments with epidermal growth factor receptor (EFGR) - Tyrosine kinase inhibitor (TKI). Lung cancer is still an area with high unmet need for early diagnosis and limited treatment options in the advanced stages of lung cancer.
- Published: November 2011
- Price: $ 4950
- TOC Available:
-
Acute Lymphocytic/Lymphoblastic Leukemia Therapeutics Market – (Pipeline Forecast & Market Forecast in G8 Countries) (2011 – 2020)
The incidence of acute lymphocytic leukemia is high in children from 0 to 14 years than the people aged above 14. It is the most common childhood acute lymphocytic leukemia. However, the acute lymphocytic leukemia may also occur in adults. Acute lymphocytic leukemia distribution depends on age. For instance, 30% of is diagnosed before the age of 5 and 55% of ALL age 15.The acute lymphocytic leukemia market is segmented into two types; namely childhood acute lymphocytic leukemia, and adult acute lymphocytic leukemia. The market was dominated by Hyper-CVAD regimen in 2010. However, in 2020, the market is expected to be equally dominated by Hyper-CVAD and Linker regimen.
- Published: December 2013
- Price: $ 4950
- TOC Available:
-
Chronic Lymphocytic Leukemia Therapeutics Market in G8 Countries (2010 - 2020)
Chronic lymphocytic leukemia is the second most common cancer in adult males and rarely occurs in children. The risk of chronic lymphocytic leukemia is closely associated with age. About 90% of chronic lymphocytic leukemia is diagnosed in middle age. Incidence rate of CLL is high in men and women over 50 years of age. The chronic lymphocytic leukemia market is segmented into two types; namely childhood chronic lymphocytic leukemia and adulthood lymphocytic leukemia. The market was dominated by Campath drug in 2010. However, in 2020, the market is expected to be equally dominated by GA101/RG7159 molecule and Arzerra drug.
- Published: December 2011
- Price: $ 4950
- TOC Available:
-
Acute Myeloid Leukemia Therapeutics Market in G8 Countries (2010 - 2020)
Acute myeloid leukemia is the second frequent type (after acute lymphocytic leukemia) of leukemia diagnosed in infants. About 15% of children from birth to 19 years of age diagnosed with leukemia have acute myeloid leukemia. The risk of acute myeloid leukemia is closely associated with age. About 90% of acute myeloid leukemia is diagnosed in middle age. Incidence rate of acute myeloid leukemia is high in men and women over 50 years. The acute myeloid leukemia market is segmented into two types; namely childhood acute myeloid leukemia and adulthood acute myeloid leukemia. The market was dominated by AVD regimen in 2010. However, in 2020, the market is expected to be dominated by AVD regimen, Cyatarabine, and Quizartinib drug.
- Published: March 2026
- Price: $ 4950
- TOC Available:
-
Global Nanomedical Devices and Therapeutics Market (2011-2016)
Nanomedicine, an application of nanotechnology in medical science, is an evolving market. It represents an important segment of nanotechnology which will significantly change the course of treating life threatening diseases. This, unlike other treatment options, is significantly expected to enhance efficacy and minimize overall adversities. Toxicity and environmental impact of nanoscale materials are the major problems nanomedicine. Research and development in nanomedicine is expected to offer a pool of novel products which will improve the health of patients. The robust product pipeline for nanobiomaterials poses a health picture of the market creates significant growth opportunities. However these will have to go through stringent testing protocols before commercialization.
- Published: March 2026
- Price: $ 4950
- TOC Available:
-
Digital Twin in Aviation Market by End Use, End User (MRO, OEM, Airline), Technology, Usage Type (Product Digital Twin, Process Digital Twin, System Digital Twin), Application and Region - Global forecast to 2025
The growth in the market is attributed to increasing development of advance aircraft manufacturing and maintenance technology. The Digital Twin in Aviation Market is expected to grow at a significant rate during the forecast period irrespective of a drop-in revenue in 2020, due to the outbreak of COVID-19. One of the major factors driving the market is the increasing demand for optimized and efficient manufacturing and maintenance process in aviation industry.
- Published: March 2026
- Price: $ 4950
- TOC Available:
-
Europe Healthcare Analytics Market by Type (Predictive, Diagnostic), Application (Claim, RCM, Fraud, Precision Health, RWE, Imaging, Supply Chain, Population Health), End User (Payer, Hospital, ASC) Market Size, Opportunities, Trends - Forecast to 2030
The Europe healthcare analytics market, valued at US$14.17 billion in 2024, stood at US$17.47 billion in 2025 and is projected to advance at a resilient CAGR of 23.9% from 2024 to 2030, culminating in a forecasted valuation of US$50.91 billion by the end of the period. This has driven the demand for analytics solutions that can better facilitate clinical decision-making, operational efficiency, and value-based healthcare delivery within the healthcare system in Europe.
- Published: January 2026
- Price: $ 4950
- TOC Available:
-
IoT Insurance Market by Type (P&C, Health, Life), Application (Automotive & Transportation, Home & Commercial Buildings, Life & Health, Business & Enterprise, Consumer Electronics, Travel, Agriculture), and Geography - Global Forecast to 2022
The global IoT insurance market is estimated to grow at a CAGR of 65.89% to reach USD 42.76 Billion by 2022. The growing adoption of Internet of Things (IoT) products in developed and developing economies, growing demand for cloud platform and other value-added services in the insurance industry are the major drivers for this market.
- Published: January 2017
- Price: $ 4950
- TOC Available:
-
Ergometers Market by Product (Ergometer treadmills, Ergometer bikes, Ergometer rowing, & others), Application (Sports & Health), End User (Hospitals& Private Clinics, Health clubs/ Gyms, Home consumers, & others) - Global Forecast to 2023
The global ergometers market is expected to reach USD 1.2 billion by 2023 from USD 1.1 billion in 2018, growing at a CAGR of 2.3%. Increasing awareness about fitness and sports, increasing per capita expenditure, and technological advancements are some of the factors driving the demand for ergometer market.
- Published: March 2026
- Price: $ 4950
- TOC Available:
Records 11 to 20 of 50
